BioNTech SE (BNTX) Reports Q3 EPS of EUR12.35

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. BROS
5. FIS
6. DDOG
7. QCOM
8. EW
9. ZG
10. W

Go back to BioNTech SE (BNTX) Reports Q3 EPS of EUR12.35

BioNTech Announces Third Quarter 2021 Financial Results and Corporate Update

November 9, 2021 6:45 AM EST

Delivered more than 2 billion doses of COMIRNATY/BNT162b2 in 2021 as of November 2ndDemonstrated progress in expanding access to COVID-19 vaccine globally, including Biologics License Application (BLA) approval by U.S. FDA, regulatory authorizations of booster doses in multiple populations and first U.S. Emergency Use Authorization (EUA) in children for a COVID-19 vaccineExpansion of clinical oncology portfolio with first patient dosed in Phase 2 trial of mRNA-based individualized immunotherapy autogene cevumeran (BNT122, RO7198457) in circulating tumor DNA positive high-risk colorectal cancer patients after... More